COVID-19 Pandemic Review On Demand

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 1B (CVD19P1B) To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Short Course:
CVD19P1B-H
Short Course Price:
$250
Format:
Available in Audio format.
Only Available Option: Short Course/Part B

Course Topics

Highlights from the 4th Annual Innovations in Cardiovascular Diagnosis and Therapy

Diagnose and treat the thromboembolic complications associated with COVID-19 virus infection; Recommend medications for, and duration of, antiplatelet therapy; List trials of antiplatelet therapies and explain their significance; Explain the role of sodium-glucose cotransporter-2 inhibitors and vericiguat in the treatment of HF; Implement cardiopulmonary stress testing to assess appropriateness of heart transplantation for a patient with advanced heart disease.

COVID-19: Treatments and Vaccines

Develop an overall treatment strategy for hospitalized patients with COVID-19; List all the effective antiviral and immunomodulatory therapies for patients infected with COVID-19; Explain the current landscape of vaccine development for COVID-19; Cite guideline recommendations of the National Institutes of Health and Infectious Disease Society of America regarding therapies for COVID-19; Optimize use of immunomodulators during the immuneinflammatory phase of the disease.

QUALIFIES FOR INFECTIOUS DISEASE; THIS IS A RETREAD OF OB6803, QUALIFIES FOR CLINICAL PHARMACOLOGY

COVID-19 Update

Counsel patients about activities that place them at highest risk for contracting COVID-19; Identify patients who are at risk for severe outcomes of COVID-19 based on comorbid conditions; Recommend appropriate isolation periods for asymptomatic and symptomatic patients with positive COVID-19 test results; Predict risk for severe outcomes among patients with different types of rheumatic diseases; Manage the use of disease-modifying antirheumatic drugs in patients who test positive for COVID-19.

QUALIFIES FOR INFECTIOUS DISEASE

Hospital Readmissions/Telemedicine

Identify patients who are at high risk for hospital readmission; Develop strategies to reduce hospital readmissions; Utilize hospital and community resources to create personalized discharge plans that reduce hospital readmission; Review recent regulatory and billing changes in telemedicine that occurred after the start of the COVID-19 pandemic; Create strategies for incorporating telemedicine into clinical practice.

Highlights from State of the Art: Kidney and Pancreas Transplantation

Recognize the importance of telemedicine for the delivery of health care during and after the COVID-19 pandemic; Optimize the selection and management of living organ donors through telemedicine; Identify social determinants of health for COVID-19 and its impact on transplant patients; Describe the demographics of the COVID-19 pandemic?s effect on the general and transplant populations; Recognize the financial and mental health impacts of COVID-19, particularly in the kidney transplant population.

Accreditation